AP
HUM icon

Antipodes Partners’s Humana HUM Stock Holding History

Antipodes Partners’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5K Buy
+112
New +$31.9K ﹤0.01% 115

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Antipodes Partners's HUM Position: Q2 2026 in Review

Antipodes Partners opened a new position in Humana (HUM) in Q2 2026: 112 shares worth $44.5K. The stake represents ﹤0.01% of the portfolio and ranks #115 among its holdings.

923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Antipodes Partners held 112 shares of Humana worth $44.5K as of Q2 2026.
  • Humana was a new Antipodes Partners position in Q2 2026.
  • Humana made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #115 holding.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.